PRF Hair Restoration In Weston, FL
PRF, or platelet-rich fibrin, is a scalp treatment made from a small draw of your own blood. The blood is spun in a centrifuge with no anticoagulant and no additives, and the fibrin-rich layer goes into thinning areas of your scalp. It works on follicles that still make hair. It does not bring back scalp that has gone smooth.
In-person and telehealth appointments available
What PRF Does To A Follicle
PRF concentrates platelets and white cells from your blood into a fibrin scaffold, and that scaffold releases growth factors into the tissue over days instead of hours. The working theory is that those signals reach stem cells in the follicle bulge and the dermal papilla, push resting follicles back into their growing phase, and improve blood supply around the follicle.
That is the mechanism. It is plausible and it is well described in the literature. It is also the part every clinic page in South Florida already tells you.
The part they skip is that a mechanism is not an outcome. A follicle has to still be there for any of it to matter.
Nothing is added to the tube. No anticoagulant, no separating gel, no additives at all, which is what makes it PRF and also what makes it a race. The fibrin starts to set. Gupta’s 2026 review puts the working window at roughly 20 minutes, so the draw, the spin and the injection all happen inside one visit, back to back, with no room to reschedule the second half.
What The 2026 Evidence Actually Shows
3 papers carry the weight. Each one is worth reading and each one has a hole in it.
The most-quoted PRF number comes from Yao and colleagues in Archives of Dermatological Research, 2025. They gave 6 monthly injectable PRF sessions to 30 androgenetic alopecia patients who had responded inadequately to conventional treatment. 80% responded by the 6-month mark, and the conclusion credits improvement in hair density. Here is the hole. It was a prospective single-center study with no comparison group, so the 80% is measured against each patient’s own baseline and nothing else. Shaft diameter was 1 component of a composite score, not a standalone finding, and the paper does not report whether the patients were men or women.
The trial that actually changed something ran the following year. Li and colleagues, in the Journal of Dermatological Treatment, 2026, ran a randomized study across multiple centers. 74 women with Sinclair grade II-III finished 24 weeks across 4 monthly sessions. Non-vellus target area hair count rose 26.5% in the injectable PRF group, and that group had the lowest adverse event rate in the study. The holes: women only, a single trial nobody has repeated, and 74 is who finished rather than who enrolled. Per-arm numbers and the adverse event rates are not in the public abstract. One more thing we will say out loud, because it is in the paper and most pages would leave it out: injectable PRF was not the highest-scoring preparation the researchers tested.
The third paper is the one that calibrates the other two. Gupta and colleagues, in Medical Sciences, 2026, scoped 101 studies published between 2020 and 2025. On PRF their sentence is short: it has been tried in 4 studies, with hair density improving for up to 6 months, and none of those studies reported their platelet counts.
Sit with that last clause for a second, because it is the most useful sentence written about PRF and hair. Platelets are the active ingredient. If a study does not report how many went in, nobody can tell you what dose produced the result, or reproduce it, or check whether the clinic down the road is giving you the same thing.
Now the endpoint. Every PRF hair result published so far is a density result, meaning how many hairs occupy a square centimeter. None of them is a thickness result, meaning how fat each individual strand is. Half the pages selling this in Florida promise you thicker hair. No PRF study has measured that and shown it.
Scalp Use Is Off-Label. Here Is The Exact Position
The FDA does not approve PRF as a treatment for hair loss. What it clears is the hardware, and it clears that hardware for other jobs.
These devices sit under more than 1 product code. Centrifuges for preparing cell and plasma concentrate are QBV, 21 CFR 862.2050, Class I. Point-of-care platelet gel systems are PMQ, 21 CFR 864.9245, Class II. Every clearance we could find covers preparing the blood product. None of them mentions a scalp.
The cleanest illustration is recent. In February 2026 the FDA cleared a system called PRF-Matrix, BK251232, made by Royal Wound-X. Its cleared use, under the supervision of a healthcare professional, is a gel applied topically for management of cutaneous wounds such as diabetic ulcers, venous leg ulcers, and mechanically or surgically debrided wounds. Hair, scalp and alopecia appear nowhere in it. A device can carry PRF in its name and still be cleared for something that has nothing to do with your head.
A second correction is worth making, because it circulates widely and it is wrong. Some clinics justify autologous scalp injections by pointing to the “same surgical procedure” exception at 21 CFR 1271.15(b). That exception does not apply here. Footnote 13 of the FDA’s guidance on that exception states that blood products are not considered HCT/Ps, so the exception is not applicable to them. Scalp PRF is off-label practice of medicine. That is the accurate framing, and it is a normal, legal category that covers a great deal of good care.
We say this out loud in the consult room. A clinic that will not say the word off-label to your face is telling you how it handles the questions that are harder than this one.
Who We Turn Away
PRF acts on follicles that are still alive and still miniaturized. Where the follicle is gone, it is gone. In primary cicatricial alopecia the follicle is destroyed and replaced with fibrous tissue, and the Canadian Medical Association Journal review of the condition states it plainly: any follicle destroyed by primary cicatricial alopecia will never regrow hair.
So we do not treat, and will tell you at the consult:
- Scalp that has been fully smooth for years, with no fine hairs left when we look under magnification
- Active scarring alopecia, until it has been quiet for at least a year and usually with a dermatologist involved
- Anyone whose realistic goal is a new hairline. That is surgery, not a syringe
- Untreated thyroid disease, iron deficiency or another medical driver we have not sorted out yet. Fixing that first is cheaper and works better
If you fall into the third group, we will say so and point you toward a surgical consult rather than sell you a series that cannot deliver what you want. We would rather lose the booking than take money for the wrong treatment.
Real Patient Results
Microneedling + PRF + Exosomes — After 2 Sessions
Results vary by individual and treatment plan
Frequently Asked Questions
Does PRF hurt?
The blood draw is a blood draw. The scalp injections sting, and topical numbing takes most of it off. Patients describe pressure more than pain. In the 2026 randomized trial, the injectable PRF group had the lowest adverse event rate in the study, though the published abstract does not give the rates.
How much does it cost?
We quote at the consult, after we have seen your scalp, because the honest number depends on how much area is being treated and whether we are adding microneedling. Ask any clinic you call for 3 figures before you book: a single scalp session, a series of 3, and 12 months of maintenance, each priced with and without add-ons. If a clinic will not give you those on the phone, that is information too.
How long until I see anything?
Months, not weeks. Hair grows on its own schedule and nothing in this category shortcuts it. The 4 PRF studies that report a density gain measured it out to 6 months, and the 2026 randomized trial ran to 24 weeks. Expect to be judging photographs, not the mirror.
Will it work if I am already bald on top?
No. Read the section above on who we turn away. If there are no miniaturized hairs left in the area, no injection reaches anything.
Does it work for women?
Women are the population with the best PRF evidence right now. 74 of them with Sinclair grade II-III female pattern loss finished 24 weeks in the 2026 randomized trial, and target area hair count rose 26.5% in the injectable PRF group. One trial, not repeated.
Should I stop minoxidil or finasteride?
No. Those 2 are the only FDA-approved drugs for pattern hair loss and they carry the deepest evidence base by a wide margin. PRF goes on top of them, not instead of them.
Book A PRF Scalp Consultation In Weston
We look at the scalp under magnification, run the labs that rule out a treatable cause, and tell you plainly whether PRF is worth your money or whether you would do better with a drug you can start this week or a surgeon we do not employ.
